Bionano Genomics Inc
BNGO3.045USD
+0.095+3.22%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
9.44MCap. mercado
PérdidaP/E TTM
Más Datos de Bionano Genomics Inc Compañía
Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Información de la empresa
Símbolo de cotizaciónBNGO
Nombre de la empresaBionano Genomics Inc
Fecha de salida a bolsaAug 01, 2018
Director ejecutivoDr. R. Erik Holmlin, Ph.D.
Número de empleados98
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 01
Dirección9540 Towne Centre Drive
CiudadSAN DIEGO
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal92121
Teléfono18588887600
Sitio Webhttps://bionano.com/
Símbolo de cotizaciónBNGO
Fecha de salida a bolsaAug 01, 2018
Director ejecutivoDr. R. Erik Holmlin, Ph.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
441.00
-5.77%
Mark Adamchak
Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-2.58%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.91%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-84.26%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Mr. David Holmes
Mr. David Holmes
Investor Relations Officer
Investor Relations Officer
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
441.00
-5.77%
Mark Adamchak
Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-2.58%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.91%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-84.26%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Por negocioUSD
Nombre
Ganancia
Proporción
Consumables
3.25M
50.29%
Software
2.07M
32.03%
Instruments
689.00K
10.67%
Services and other
453.00K
7.02%
Por regiónUSD
Nombre
Ganancia
Proporción
EMEIA
3.07M
47.48%
Americas
3.06M
47.36%
Asia Pacific
333.00K
5.16%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Consumables
3.25M
50.29%
Software
2.07M
32.03%
Instruments
689.00K
10.67%
Services and other
453.00K
7.02%
Estadísticas de accionistas
Actualizado: jue., 24 de jul
Actualizado: jue., 24 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Heights Capital Management, Inc.
4.69%
The Vanguard Group, Inc.
1.49%
Everstar Asset Management LLC
1.34%
GSA Capital Partners LLP
1.19%
Geode Capital Management, L.L.C.
0.46%
Other
90.83%
Accionistas
Accionistas
Proporción
Heights Capital Management, Inc.
4.69%
The Vanguard Group, Inc.
1.49%
Everstar Asset Management LLC
1.34%
GSA Capital Partners LLP
1.19%
Geode Capital Management, L.L.C.
0.46%
Other
90.83%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
8.32%
Hedge Fund
1.19%
Investment Advisor/Hedge Fund
0.47%
Research Firm
0.33%
Individual Investor
0.06%
Bank and Trust
0.02%
Other
89.62%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
193
349.15K
10.38%
-67.10K
2025Q1
262
309.73K
9.24%
-123.47K
2024Q4
284
105.26K
3.91%
-124.97K
2024Q3
298
94.17K
6.55%
-135.04K
2024Q2
310
116.15K
9.81%
-164.95K
2024Q1
318
86.19K
9.42%
-64.99K
2023Q4
324
107.44K
14.24%
-23.70K
2023Q3
345
94.81K
16.11%
-27.58K
2023Q2
356
93.86K
18.29%
-63.50K
2023Q1
366
141.65K
27.72%
-15.82K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Heights Capital Management, Inc.
157.93K
4.69%
-20.40K
-11.44%
Mar 31, 2025
The Vanguard Group, Inc.
49.98K
1.49%
+18.64K
+59.50%
Mar 31, 2025
Everstar Asset Management LLC
44.98K
1.34%
+44.98K
--
Mar 31, 2025
Geode Capital Management, L.L.C.
15.51K
0.46%
-1.12K
-6.75%
Mar 31, 2025
Parametric Portfolio Associates LLC
11.49K
0.34%
+11.49K
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
10.10K
0.3%
-4.00
-0.04%
Mar 31, 2025
BofA Global Research (US)
8.39K
0.25%
+8.37K
+41865.00%
Mar 31, 2025
Osaic Holdings, Inc.
3.21K
0.1%
+3.03K
+1722.73%
Mar 31, 2025
UBS Financial Services, Inc.
1.91K
0.06%
-22.00
-1.14%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
Dimensional US Core Equity 1 ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
SPDR S&P Kensho New Economies Composite ETF
0%
Global X Genomics & Biotechnology ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Genomics Immunology and Healthcare ETF
0%
Global X HealthTech ETF
0%
Dimensional US Core Equity 1 ETF
Proporción0%
Invesco NASDAQ Future Gen 200 ETF
Proporción0%
SPDR S&P Kensho New Economies Composite ETF
Proporción0%
Global X Genomics & Biotechnology ETF
Proporción0%
Invesco RAFI US 1500 Small-Mid ETF
Proporción0%
Avantis US Small Cap Equity ETF
Proporción0%
iShares Genomics Immunology and Healthcare ETF
Proporción0%
Global X HealthTech ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Aug 04, 2023
Merger
10<1
Aug 04, 2023
Merger
10<1
Fecha
Tipo
Relación
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Aug 04, 2023
Merger
10<1
Aug 04, 2023
Merger
10<1
Aug 04, 2023
Merger
10<1
Aug 04, 2023
Merger
10<1
